2-YEAR CROSSOVER THERAPEUTIC TRIAL WITH HALOFENATE AND CLOFIBRATE

被引：11

作者：

DUJOVNE, CA

AZARNOFF, DL

PENTIKAINEN, P

MANION, C

HURWITZ, A

HASSANEIN, K

机构：

[1] UNIV KANSAS,MED CTR,COLL HLTH SCI,DEPT MED,CTR CLIN PHARMACOL TOXICOL,KANSAS CITY,KS 66103

[2] UNIV KANSAS,MED CTR,COLL HLTH SCI,DEPT PHARMACOL,KANSAS CITY,KS 66103

[3] UNIV KANSAS,MED CTR,COLL HLTH SCI,DEPT BIOMETRY,KANSAS CITY,KS 66103

[4] UNIV KANSAS HOSP,KANSAS CITY,KS

来源：

AMERICAN JOURNAL OF THE MEDICAL SCIENCES | 1976年 / 272卷 / 03期

关键词：

D O I：

10.1097/00000441-197611000-00005

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：277 / 284

页数：8

共 20 条

[1]

AZARNOFF DL, 1962, J LAB CLIN MED, V60, P331

[2]

BEAUMONT JL, 1970, WHO B, V253, P891

[3]

BECKMAN L, 1964, ACTA GENET STAT MED, V14, P286

[4]

BENTON DA, 1975, NUTR REP INT, V11, P461

[5]

DUJOVNE CA, 1971, CLIN PHARMACOL THER, V12, P117

[6]

DUJOVNE CA, IN PRESS

[7] CLOFIBRATE IN ISCHEMIC-HEART DISEASE [J].

FRIEDEWALD, WT ;

HALPERIN, M .

ANNALS OF INTERNAL MEDICINE, 1972, 76 (05) :821-+

[8] PHARMACOKINETICS OF DRUGS IN PATIENTS WITH NEPHROTIC SYNDROME [J].

GUGLER, R ;

SHOEMAN, DW ;

HUFFMAN, DH ;

COHLMIA, JB ;

AZARNOFF, DL .

JOURNAL OF CLINICAL INVESTIGATION, 1975, 55 (06) :1182-1189

[9]

HALL ARTHUR P., 1965, ARTHRITIS RHEUM, V8, P846, DOI 10.1002/art.1780080449

[10] EFFECT OF HALOFENATE ON BINDING OF VARIOUS DRUGS TO HUMAN PLASMA-PROTEINS AND ON PLASMA HALF-LIFE OF ANTIPYRINE IN MONKEYS [J].

HUCKER, HB ;

WHITE, SE ;

STAUFFER, SC .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1972, 61 (09) :1490-&

← 1 2 →